Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LOMUSTINE vs LONCASTUXIMAB TESIRINE-LPYL: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

LOMUSTINE vs LONCASTUXIMAB TESIRINE-LPYL: Safety Overview

Metric LOMUSTINE LONCASTUXIMAB TESIRINE-LPYL
Total FAERS Reports 1,614 202
Deaths Reported 431 58
Death Rate 26.7% 28.7%
Hospitalizations 418 34
Average Patient Age 45.5 yrs 77.3 yrs
% Female Patients 42.5% 48.1%
FDA Approval Date Approved Prior to Jan 1, 1982 N/A
Manufacturer Carnegie Pharmaceuticals LLC N/A
Route ORAL N/A
Marketing Status Prescription Prescription